Santen Pharmaceutical. (SZD.F) Q3 2024 Earnings

6AugConfirmed
Dec 17
Q4 2023
Q2 2024
Q3 2024
0.1
9.97
19.84
29.71

Details

Expected EPS
0.14776375029937727
Actual EPS
0.16823675960079998
Surprise EPS
0.02
Surprise Percent
+13.86%

Description

Santen Pharmaceutical. (SZD.F) has reported earnings of 0.16823675960079998 per share for Q3 2024.

0 Comments

Share your thoughts